key: cord-0986989-yr97chgc
authors: Gao, Ya; Liu, Ming; Chen, Yamin; Shi, Shuzhen; Geng, Jie; Tian, Jinhui
title: Association between tuberculosis and COVID‐19 severity and mortality: A rapid systematic review and meta‐analysis
date: 2020-07-28
journal: J Med Virol
DOI: 10.1002/jmv.26311
sha: 9f50dcf56dd30947a9178905bdc4621b74d88548
doc_id: 986989
cord_uid: yr97chgc

Coronavirus Disease 2019 (COVID-19) has become a pandemic and the number of infected cases continues to rise. As of July 8, 2020, a total of 11,669,259 laboratory-confirmed cases were reported worldwide, with a mortality rate of 4.6% 1 . This article is protected by copyright. All rights reserved.

Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis

To the Editor, Coronavirus Disease 2019 (COVID-19) has become a pandemic and the number of infected cases continues to rise. As of 8 July 2020, a total of 11 669 259 laboratory-confirmed cases were reported worldwide, with a mortality rate of 4.6%. 1 Previous meta-analyses have shown that chronic obstructive pulmonary disease (COPD), cerebrovascular disease, hypertension, diabetes, and cardiovascular disease were risk factors for disease progression in patients with COVID-19. 2, 3 However, to be the best of our knowledge, no meta-analysis has yet evaluated the impact of tuberculosis on COVID-19 severity and mortality. Therefore, we performed a systematic review and meta-analysis to assess whether tuberculosis is associated with an increased risk of severe disease and death in patients with COVID-19.

This meta-analysis was conducted following the Preferred Reporting in Systematic Reviews and Meta-Analyses (PRISMA) statement. 4 We have registered this review protocol in the International Prospective We used a predefined form to extract data from included studies.

The data included first author, publication year, publication language, country of the corresponding author, recruitment time frame, age and sex of patients, sample size, the prevalence of tuberculosis, and outcomes of interest. The Newcastle-Ottawa Quality Assessment Scale (NOS) was used to assess the quality of included studies. The data abstraction was conducted by one reviewer and verified by another.

The primary outcome was the association between tuberculosis and the risk of severe disease in patients with COVID-19. The secondary outcome was the association between tuberculosis and COVID-19 mortality. We adopted the Review Manager (version 5.3) to estimate pooled odds risk (OR) and its 95% confidence interval (CI) for primary and secondary outcomes using the inverse variance statistical method.

Owing to heterogeneity within and between studies, we performed metaanalyses using the random-effects model. We assessed the heterogeneity using Cochran's Q test and I 2 statistic, and I 2 values of less than 25%, 26% to 50%, and more than 50% were considered as low, moderate, and high degrees of heterogeneity, respectively. Stata 13.0 (Stata Corporation, College Station, TX) was used to conduct a meta-regression analysis to explore whether the primary outcome or the heterogeneity was associated with the mean age of patients.

We identified 2932 records through systematic electronic searches.

After screening titles, abstracts, and full texts, six studies 7-12 were in- (Table 1) .

Four studies 7-10 involving 2,383 patients reported the prevalence of tuberculosis between severe and non-severe COVID-19 patients. The meta-analysis indicated the prevalence of tuberculosis in severe patients (1.47%, 10/680) was higher than that in non-severe patients (0.59%; 10/1703) (OR = 2.10, 95%CI: 0.61 to 7.18; P = .24; I 2 = 36%), although the statistical difference was not significant ( Figure 1A) . The univariate meta-regression analysis indicated the mean age of patients was not the source of heterogeneity or the factor affecting the correlation between tuberculosis and COVID-19 severity (P = .469; Figure 2 ). Two studies 11, 12 provided the prevalence of tuberculosis between surviving and dying COVID-19 patients. Chen et al 's study 11 revealed that non-survivors had a higher prevalence of tuberculosis than survivors Having a reliable estimate of the association between tuberculosis and COVID-19 severity and mortality is crucial to ensure specific successful global preventive and treatment strategies for tuberculosis patients. Our study revealed that tuberculosis was associated with a 2.10fold increased risk of severe COVID-19 disease, although the statistical difference was not significant. When a patient suffers from a previous respiratory disease, the patient's lung function is impaired, and their resistance to viruses is low and they tend to develop ARDS. 2 

World Health Organization. Coronavirus disease (COVID-2019) situation reports

Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis

Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Impacts of immunosuppression and immunodeficiency on COVID-19: systematic review and meta-analysis

Drinking no-links to the severity of COVID-19: a systematic review and meta-analysis

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

A study of laboratory confirmed cases between laboratory indexes and clinical classification of 342 cases with corona virus disease 2019 in Ezhou

The clinical features of the 143 patients with COVID-19 in North-East of Chongqing

Clinical outcomes of COVID-19 cases and influencing factors in Guangdong province

Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study